Landscape Capital Management L.L.C. trimmed its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 19.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,377 shares of the company’s stock after selling 580 shares during the period. Landscape Capital Management L.L.C.’s holdings in Cardinal Health were worth $263,000 as of its most recent filing with the SEC.
Several other large investors have also recently made changes to their positions in CAH. Paragon Capital Management Inc. boosted its holdings in Cardinal Health by 0.7% during the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock valued at $1,451,000 after acquiring an additional 99 shares during the period. Midland Wealth Advisors LLC boosted its stake in shares of Cardinal Health by 4.2% in the second quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company’s stock valued at $245,000 after purchasing an additional 100 shares during the period. Aptus Capital Advisors LLC increased its stake in Cardinal Health by 5.1% during the 2nd quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company’s stock worth $204,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund lifted its holdings in Cardinal Health by 0.5% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company’s stock worth $2,054,000 after buying an additional 100 shares in the last quarter. Finally, Huntington National Bank boosted its position in Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock valued at $1,193,000 after buying an additional 100 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts have recently issued reports on CAH shares. Barclays increased their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Robert W. Baird upped their target price on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $123.00.
Cardinal Health Stock Down 0.1 %
Shares of Cardinal Health stock opened at $121.77 on Tuesday. The firm has a market capitalization of $29.47 billion, a P/E ratio of 23.69, a P/E/G ratio of 1.52 and a beta of 0.60. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $126.14. The firm’s 50 day moving average is $114.07 and its two-hundred day moving average is $106.13.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company’s revenue was down 4.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.73 earnings per share. As a group, research analysts expect that Cardinal Health, Inc. will post 7.83 earnings per share for the current fiscal year.
Cardinal Health Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health’s payout ratio is currently 39.30%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Using the MarketBeat Dividend Yield Calculator
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Options Trading – Understanding Strike Price
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.